Sign Up Today and Learn More About Seneca Therapeutics Stock
Invest in or calculate the value of your shares in Seneca Therapeutics or other pre-IPO companies through EquityZen's platform.
Seneca Therapeutics Stock
Seneca is a biotechnology company that focuses on developing novel oncolytic immunotherapeutics for the treatment of cancer.
About Seneca Therapeutics Stock
Founded
2018
Headquarters
Blue Bell, PA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Seneca Therapeutics Press Mentions
Stay in the know about the latest news on Seneca Therapeutics
Seneca valley virus mutants
patents • Feb 01, 2026
Seneca Therapeutics Announces the Closing of $3.9 million Series B Extension Round
einpresswire • Aug 29, 2025
Cancer therapies with oncolytic virus and an immune checkpoint inhibitor
patents • Feb 08, 2025
Neuroendocrine Tumors Pipeline Insights, Clinical Trials Analysis, Emerging Drugs and Companies | DelveInsight
einpresswire • Jan 22, 2025
Keiretsu Forum Mid-Atlantic, South-East, Texas’ Investor Capital Expo Honors Top Startups with the Stephen M. Goodman Most Valued Company Award
globenewswire • Nov 06, 2024
Seneca Therapeutics Management
Leadership team at Seneca Therapeutics
CEO and Founder
Paul Hallenbeck
Join now and verify your accreditation status to gain access to:
- Seneca Therapeutics Current Valuation
- Seneca Therapeutics Stock Price
- Seneca Therapeutics Management
- Available deals in Seneca Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Seneca Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Seneca Therapeutics Revenue and Financials
- Seneca Therapeutics Highlights
- Seneca Therapeutics Business Model
- Seneca Therapeutics Risk Factors
- Seneca Therapeutics Research Report from SACRA Research
Trading Seneca Therapeutics Stock
How to invest in Seneca Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Seneca Therapeutics through EquityZen funds. These investments are made available by existing Seneca Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Seneca Therapeutics stock?
Shareholders can sell their Seneca Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 440K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 53K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."